Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Health & Science Companies Health care industry
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets Investment Strategy Hims & Hers Health Inc
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags UnitedHealth Group Inc Health care industry Breaking News: Politics
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Technology Streaming media technology Government and politics
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Technology Government and politics Asia Markets
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags U/S/ Markets Diabetes Health care costs
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Novo Nordisk A/S Science Biotechnology
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Technology Novo Nordisk A/S Oracle Corp
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Science Novo Nordisk A/S Viking Therapeutics Inc
From CNBC.com News
5 things to know before the stock market opens
Tags Nasdaq Inc Economy Walt Disney Co
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags China Economy Eli Lilly and Co Europe News
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotech and Pharmaceuticals Business News Novo Nordisk A/S
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Breaking News: Markets Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Biotech and Pharmaceuticals Healthy Returns Social issues
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags CNBC Changemakers Biotech and Pharmaceuticals Business
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Markets World Economy Prices
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health & Science Small Business Small Business Playbook
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Health & Science Companies Health care industry
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Novo Nordisk A/S Business News Market Outlook
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Markets stocks Eli Lilly and Co
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Internet Breaking News: Technology Mobile
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Biotech and Pharmaceuticals Eli Lilly and Co Healthy Returns
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Business News Health care industry Health & Science
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Novo Nordisk A/S Technology Enterprise
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Alphabet Inc Science Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Social issues Biotech and Pharmaceuticals Business News
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Novo Nordisk A/S Health & Science Health care industry
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Eli Lilly and Co US: News Pharmaceuticals
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.